department

Clinical
Regulatory
Medical Affairs
Commercial
R&D / Discovery
Biostatistics / Data
Manufacturing / CMC
Market Access

therapeutic area

Oncology
Immunology
Neuroscience
Cardiovascular
Metabolic
Rare Disease
Infectious Disease

location & type

Remote Only
US Only
California
Massachusetts
Internships
Phase 3 Roles
All Jobs →

when

Latest
Archive

by source

All Sources
Sources Page

by activity

Most Active
Biggest Pipelines
Recently Active

hiring

Companies Hiring Now
Big Pharma Roles
All Companies →

Drugs & Pipeline

intelligence

Drugs
Patent Cliff

research

Publications
Topics

window

Next 90 Days
All (incl. Past)

by type

PDUFAs
Approvals
Earnings
Readouts

Sign In Subscribe

pharmadog

fetch the data · sniff the signal

Discover

Calendar
Drugs
Companies
News

Hubs

Topics
Jobs
Patent cliff
Publications

Tools

Compare
Search
Bookmarks

Trust

About
Sources
Contact

Legal

Privacy
Terms
Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

home
jobs
news
cal
search

PMV Pharmaceuticals, Inc. ($PMVP) · pharmadog

PUBLIC COMPANY

$PMVPPMV Pharmaceuticals, Inc.

Princeton, NJ, USupdated 1mo ago

SEC EDGAR ↗Yahoo Finance ↗

community read0 votes

pipeline

1

marketed

0

phase 3

0

catalysts ytd

0

approvals ytd

0

recalls ytd

0

Pipeline(1)

pipeline depth1 products

1Phase 2

Bile Duct Cancer (Cholangiocarcinoma)

Upcoming

no upcoming catalysts on record

Recent(90d)

nothing in the last 90 days

view all catalysts →

🐶 Hiring Signal

No open roles indexed yet — view PMV Pharmaceuticals, Inc. jobs →

News

no news has mentioned this company yet

identifiers

ticker

$PMVP

SEC CIK

0001699382

country

US

source

sec_tickers

top tags

Colorectal Cancer1 NSCLC1 Oncology1 Prostate Cancer1

mentioned in

0news items

entity-linker matched

Active trials

phase1A Study to Investigate the Effects of Multiple Doses of Rezatapopt on the Pharmacokinetics of Metformin, Rosuvastatin, Repaglinide, and Midazolam in Patients With Advanced Solid Tumors Harboring a TP53 Y220C Mutation.recruitingn=14
phase2The Evaluation of PC14586 in Patients With Advanced Solid Tumors Harboring a TP53 Y220C Mutation (PYNNACLE)recruitingn=300
phase1A Study to Investigate the Effects of Itraconazole on the Pharmacokinetics of PC14586 in Healthy Participantscompletedn=12
phase1Effect of Food on PC14586 in Healthy Volunteers and the PK of PC14586 in Healthy Japanese Volunteerscompletedn=34
phase1A Study to Investigate the Effects of Acid Reducing Agents on Pharmacokinetics of PC14586 in Healthy Participantscompletedn=28

$PMVP

Insider activity

source: SEC Form 4

routine RSU / option mechanics (4)

Mar 5, 26grantCarulli Michael · Chief Financial Officer240,000 sh
Mar 5, 26grantTicktin Robert · General Counsel & COO319,270 sh
Mar 5, 26grantJalota Deepika · Chief Development Officer303,310 sh
Mar 5, 26grantMack David Henry · President and CEO744,960 sh

comments(0)

5-min edit window · permanent after that

sign in to leave a comment · permanent archive after 5 minutes

no comments yet — first sniff?

Data sources

last refreshed 31m ago

Found something off?

🐶 something off?

Report a data issue

Tell Bork what looks wrong — wrong sponsor, stale phase, mislinked ticker, anything. We’ll triage and fix.